Ann: Change to Board Composition, page-10

Pls peeps. How about a bit of fairness and rationality in the comments. Put simply, we were invested in a company whose IP failed in the normal course of scientific testing. Naturally, this is a common occurrence. Why, in retrospect, belittle management.

Yeah, in retrospect there may be a bit of a smell about some aspects of the TIS days, but I think we should accept that FTT played by the rules and did their best to demonstrate their risk assessed view that we were on a winner. Unfortunately they were wrong and all who invested lost on a fair and square gamble.

Take the risk, accept the result. No sour grapes from me.